Chengdu Easton Biopharmaceuticals Co., Ltd. (SHA:688513)
China
· Delayed Price · Currency is CNY 63.76
-0.27 (-0.42%)
Apr 29, 2026, 3:00 PM CST
SHA:688513 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 326.01 | 855.43 | 971.4 | 781.23 | 830.97 | 1,051 | Upgrade
|
| Trading Asset Securities | 1,296 | 758 | 452.35 | 741.78 | 516.36 | 453.84 | Upgrade
|
| Cash & Short-Term Investments | 1,622 | 1,613 | 1,424 | 1,523 | 1,347 | 1,505 | Upgrade
|
| Cash Growth | 8.61% | 13.32% | -6.52% | 13.04% | -10.45% | -7.43% | Upgrade
|
| Accounts Receivable | 213.47 | 257.78 | 288.44 | 177.7 | 180.92 | 126.73 | Upgrade
|
| Other Receivables | 0.44 | 0.31 | 0.44 | 0.66 | 1.25 | 0.17 | Upgrade
|
| Receivables | 213.91 | 258.09 | 288.88 | 178.36 | 182.17 | 126.9 | Upgrade
|
| Inventory | 246.66 | 228.71 | 190.09 | 160.98 | 140.87 | 103.68 | Upgrade
|
| Prepaid Expenses | - | - | 4.22 | 4.1 | 12.78 | 3.2 | Upgrade
|
| Other Current Assets | 35.28 | 31.93 | 21.76 | 16.41 | 25.97 | 40.76 | Upgrade
|
| Total Current Assets | 2,117 | 2,132 | 1,929 | 1,883 | 1,709 | 1,779 | Upgrade
|
| Property, Plant & Equipment | 1,213 | 1,224 | 1,249 | 1,255 | 1,141 | 874.59 | Upgrade
|
| Long-Term Investments | 76.86 | 71.21 | 80.71 | 81.08 | 46.66 | - | Upgrade
|
| Goodwill | 23.1 | 23.1 | - | - | - | - | Upgrade
|
| Other Intangible Assets | 202.06 | 207.01 | 35.6 | 34.46 | 34.61 | 33.71 | Upgrade
|
| Long-Term Deferred Tax Assets | 25.48 | 23.68 | 11.5 | 8.57 | 8.73 | 12.16 | Upgrade
|
| Long-Term Deferred Charges | 101.07 | 99.17 | 77.51 | 54.92 | 45.36 | 12.35 | Upgrade
|
| Other Long-Term Assets | 18.93 | 17.34 | 16.73 | 29.89 | 32.09 | 63.39 | Upgrade
|
| Total Assets | 3,777 | 3,798 | 3,400 | 3,347 | 3,018 | 2,775 | Upgrade
|
| Accounts Payable | 105.03 | 124.98 | 144.35 | 180.94 | 156.86 | 203.92 | Upgrade
|
| Accrued Expenses | 26.24 | 49.41 | 266.85 | 218.97 | 190.72 | 156.1 | Upgrade
|
| Short-Term Debt | 45.38 | 110.71 | 74.44 | 180.95 | 105.29 | 20.02 | Upgrade
|
| Current Portion of Long-Term Debt | 4.4 | 4.4 | 3.67 | 2.93 | - | - | Upgrade
|
| Current Income Taxes Payable | 29.37 | 30.58 | 4.62 | 3.34 | 1.46 | 2.71 | Upgrade
|
| Current Unearned Revenue | 27.89 | 23.31 | 38.28 | 31.98 | 28.71 | 10.99 | Upgrade
|
| Other Current Liabilities | 315.34 | 275.31 | 64.12 | 41.98 | 46.35 | 38.72 | Upgrade
|
| Total Current Liabilities | 553.64 | 618.7 | 596.32 | 661.09 | 529.39 | 432.46 | Upgrade
|
| Long-Term Debt | 31.56 | 31.53 | 35.93 | 39.6 | - | - | Upgrade
|
| Long-Term Unearned Revenue | 60.83 | 62.49 | 68.25 | 41.18 | 42.81 | 51.03 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 45.47 | 46.19 | 1.7 | 1.46 | 0.88 | 0.12 | Upgrade
|
| Total Liabilities | 691.49 | 758.9 | 702.21 | 743.33 | 573.08 | 483.6 | Upgrade
|
| Common Stock | 176.53 | 176.53 | 176.53 | 120.09 | 120.09 | 120.09 | Upgrade
|
| Additional Paid-In Capital | 1,407 | 1,404 | 1,388 | 1,444 | 1,444 | 1,444 | Upgrade
|
| Retained Earnings | 1,470 | 1,419 | 1,208 | 1,040 | 880.3 | 727.45 | Upgrade
|
| Treasury Stock | -67.67 | -67.67 | -76.22 | -1.59 | - | - | Upgrade
|
| Comprehensive Income & Other | 1.74 | 1.26 | 1.02 | 0.99 | 0.02 | 0.07 | Upgrade
|
| Total Common Equity | 2,987 | 2,933 | 2,698 | 2,603 | 2,444 | 2,292 | Upgrade
|
| Minority Interest | 98.59 | 106.14 | - | - | - | - | Upgrade
|
| Shareholders' Equity | 3,086 | 3,039 | 2,698 | 2,603 | 2,444 | 2,292 | Upgrade
|
| Total Liabilities & Equity | 3,777 | 3,798 | 3,400 | 3,347 | 3,018 | 2,775 | Upgrade
|
| Total Debt | 81.33 | 146.65 | 114.04 | 223.48 | 105.29 | 20.02 | Upgrade
|
| Net Cash (Debt) | 1,540 | 1,467 | 1,310 | 1,300 | 1,242 | 1,485 | Upgrade
|
| Net Cash Growth | 14.09% | 11.99% | 0.78% | 4.63% | -16.33% | -6.35% | Upgrade
|
| Net Cash Per Share | 8.88 | 8.42 | 7.48 | 7.34 | 7.03 | 8.43 | Upgrade
|
| Filing Date Shares Outstanding | 175.28 | 168.69 | 174.08 | 174.93 | 176.53 | 176.53 | Upgrade
|
| Total Common Shares Outstanding | 175.28 | 168.69 | 174.08 | 176.49 | 176.53 | 176.53 | Upgrade
|
| Working Capital | 1,564 | 1,513 | 1,332 | 1,222 | 1,180 | 1,347 | Upgrade
|
| Book Value Per Share | 17.04 | 17.39 | 15.50 | 14.75 | 13.85 | 12.98 | Upgrade
|
| Tangible Book Value | 2,762 | 2,703 | 2,662 | 2,569 | 2,410 | 2,258 | Upgrade
|
| Tangible Book Value Per Share | 15.76 | 16.02 | 15.29 | 14.56 | 13.65 | 12.79 | Upgrade
|
| Buildings | - | - | 775.81 | 724.27 | 487.54 | 152.45 | Upgrade
|
| Machinery | - | - | 678.03 | 661.8 | 673.35 | 279.81 | Upgrade
|
| Construction In Progress | - | - | 189.56 | 186.26 | 231.12 | 637.88 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.